Actinium Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Actinium Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 111 %, a 32.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 111 +27.2 +32.6% Sep 30, 2024
Q2 2024 108 +33.7 +45.4% Jun 30, 2024
Q1 2024 102 +35.7 +53.7% Mar 31, 2024
Q4 2023 95.3 +45.2 +90.2% Dec 31, 2023
Q3 2023 83.4 +48.6 +139% Sep 30, 2023
Q2 2023 74.2 +54.1 +270% Jun 30, 2023
Q1 2023 66.5 +59.7 +874% Mar 31, 2023
Q4 2022 50.1 +43.7 +689% Dec 31, 2022
Q3 2022 34.9 +28.9 +481% Sep 30, 2022
Q2 2022 20.1 +12.9 +180% Jun 30, 2022
Q1 2022 6.83 -1.81 -20.9% Mar 31, 2022
Q4 2021 6.34 -6.55 -50.8% Dec 31, 2021
Q3 2021 6.01 -14.6 -70.9% Sep 30, 2021
Q2 2021 7.17 -25.9 -78.3% Jun 30, 2021
Q1 2021 8.64 -61 -87.6% Mar 31, 2021
Q4 2020 12.9 -56.5 -81.4% Dec 31, 2020
Q3 2020 20.7 -43.4 -67.7% Sep 30, 2020
Q2 2020 33.1 -23 -41% Jun 30, 2020
Q1 2020 69.6 +17.7 +34% Mar 31, 2020
Q4 2019 69.4 +32.7 +88.8% Dec 31, 2019
Q3 2019 64 +32.2 +101% Sep 30, 2019
Q2 2019 56 +28 +100% Jun 30, 2019
Q1 2019 51.9 +22 +73.6% Mar 31, 2019
Q4 2018 36.8 +3.79 +11.5% Dec 31, 2018
Q3 2018 31.8 +1.54 +5.09% Sep 30, 2018
Q2 2018 28 -3.54 -11.2% Jun 30, 2018
Q1 2018 29.9 +5.92 +24.7% Mar 31, 2018
Q4 2017 33 +14.3 +76.6% Dec 31, 2017
Q3 2017 30.3 +12.4 +69.9% Sep 30, 2017
Q2 2017 31.5 +16.6 +111% Jun 30, 2017
Q1 2017 24 +9.14 +61.5% Mar 31, 2017
Q4 2016 18.7 +2.79 +17.6% Dec 31, 2016
Q3 2016 17.8 -12.4 -41% Sep 30, 2016
Q2 2016 14.9 -50.7 -77.3% Jun 30, 2016
Q1 2016 14.9 -147 -90.8% Mar 31, 2016
Q4 2015 15.9 Dec 31, 2015
Q3 2015 30.2 Sep 30, 2015
Q2 2015 65.7 Jun 30, 2015
Q1 2015 162 Mar 31, 2015
Q4 2012 583 Dec 31, 2012
Q3 2012 55.2 Sep 30, 2012
Q2 2012 50.4 Jun 30, 2012
Q1 2012 45.9 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.